Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bortezomib, daratumumab and hyaluronidase, dexamethasone and lenalidomide that can be used for the treatment of plasma cell (multiple) myeloma.

**Synonyms:** - Bortezomib-Daratumumab and Hyaluronidase-Dexamethasone-Lenalidomide Regimen - Bortezomib-Darzalex Faspro-Dexamethasone-Lenalidomide - Bortezomib-Dexamethasone-Lenalidomide Plus Daratumumab and Hyaluronidase - Bortezomib-Dexamethasone-Lenalidomide Plus Daratumumab and Hyaluronidase-fihj - Bortezomib-Lenalidomide-Dexamethasone Plus Daratumumab and Hyaluronidase - Bortezomib/Daratumumab and Hyaluronidase-fihj/Dexamethasone/Lenalidomide Regimen - Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone/Lenalidomide - Bortezomib/Dexamethasone/Lenalidomide Plus Daratumumab and Hyaluronidase Regimen - Bortezomib/Dexamethasone/Lenalidomide Plus Darzalex Faspro - Daratumumab and Hyaluronidase-RVd Regimen - Daratumumab and Hyaluronidase-fihj/Bortezomib/Dexamethasone/Lenalidomide Regimen - Daratumumab and Hyaluronidase/Bortezomib/Dexamethasone/Lenalidomide Regimen - Daratumumab and Recombinant Human Hyaluronidase/Bortezomib/Dexamethasone/Lenalidomide Regimen - Daratumumab-Hyaluronidase/Bortezomib/Dexamethasone/Lenalidomide - Daratumumab/Hyaluronidase Plus Bortezomib-Dexamethasone-Lenalidomide - Darzalex Faspro-RVD - Darzalex Faspro-VRd - Darzalex Faspro/Bortezomib/Dexamethasone/Lenalidomide Regimen - Darzalex Faspro/Velcade/Decadron/Revlimid Regimen - RVD Plus Daratumumab and Hyaluronidase - RVD Plus Darzalex Faspro - Velcade-Decadron-Revlimid Plus Darzalex Faspro Regimen